{{Rsnum
|rsid=2157719
|Gene=CDKN2BAS
|Chromosome=9
|position=22033367
|Orientation=minus
|GMAF=0.2089
|Gene_s=CDKN2B-AS1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 31.9 | 47.8 | 20.4
| HCB | 83.9 | 15.3 | 0.7
| JPT | 78.8 | 19.5 | 1.8
| YRI | 100.0 | 0.0 | 0.0
| ASW | 93.0 | 7.0 | 0.0
| CHB | 83.9 | 15.3 | 0.7
| CHD | 77.1 | 21.1 | 1.8
| GIH | 44.6 | 44.6 | 10.9
| LWK | 98.2 | 1.8 | 0.0
| MEX | 74.1 | 24.1 | 1.7
| MKK | 93.6 | 6.4 | 0.0
| TSI | 37.3 | 50.0 | 12.7
| HapMapRevision=28
}}

{{PMID Auto GWAS
|PMID=21531791
|Trait=None
|Title=Chromosome 7p11.2 (EGFR) variation influences glioma risk.
|RiskAllele=
|Pval=5E-16
|OR=1.2600
|ORtxt=[NR]
|OA=1
}}

{{PMID Auto GWAS
|PMID=22570617
|Trait=None
|Title=Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma.
|RiskAllele=
|Pval=2E-18
|OR=1.4500
|ORtxt=None
|OA=1
}}

{{PMID|19578366|OA=1
}} Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

{{PMID Auto
|PMID=23111177
|Title=CDKN2B-AS1 Genotype-Glaucoma Feature Correlations in Primary Open-Angle Glaucoma Patients From the United States
|OA=1
}}

{{PMID Auto
|PMID=25239644
|Title=Genetic polymorphisms in the 9p21 region associated with risk of multiple cancers
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}